PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.\', \'Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.\', \'The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Hubei, P. R. China.\', \'Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Guangdong, P. R. China.\', \'Business Planning Department, Sales & Marketing Division, Medical & Biological Laboratories Co., Ltd, Tokyo, Japan.\', \'Department of Blood Transfusion, The University of Tokyo Hospital, Tokyo, Japan.\', \'Department of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.\', \'Department of Gastrointestinal Surgery, The University of Tokyo, Tokyo, Japan.\', \'Laboratory for Systems Biology and Medicine, The University of Tokyo, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0247711
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33661990
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all